Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
Onasemnogene abeparvovec alleen in basispakket na prijsonderhandeling
mei 2021 | Neuro-musculair